USE OF KALLIKREIN INHIBITOR FOR THE PRODUCTION OF A PHARMACEUTICAL FOR THE PROPHYLAXIS AND THERAPY OF CERTAIN DISEASES

摘要

Use of a kallikrein inhibitor for the production of a pharmaceutical for the prophylaxis and therapy of certain diseases The use of C1-inactivator for the production of a pharmaceutical for the prophylaxis and treatment of capillary leak syndrome (generalized extravasation) and circulatory shock (refractory hypotension) in severe burns or scalds, in polytrauma, in operations under conditions of extracorporeal circulation, in the use of cytokines, endogenous mediators, and mediator hybrids and growth factors produced by genetic engineering, or capillary leak syndrome and veno-occlusive disease of the liver in therapeutically or prophylactically indicated bone marrow transplantation is described.